From: Rodrigo Duarte, rn	Category: FDA Warnings
City:  -	Language: English

Gadolinium, which is commonly used during an MRI as a contrast agent, have a new FDA warning that they can cause NSF/NFD, nephrogenic systemic Fibrosis/Nephrogenic Fibrosing Dermopathy. These are diseases which cause fibrosis of the skin and internal organs. These problems can occur from a few days to a year after receiving the contrast agent. This videos tell you who is at risk and what the signs are.

From: Mahmood Pazirandeh, MD, FACP,FACR	Category: FDA Warnings
City: Cleveland	Language: English

Rituxan is approved for treatment of some other diseases, but not lupus. This FDA warning is for patients with lupus being treated with Rituxan. There is risk of a fatal infection of the brain called PML.

From: Randy Miller, MD	Category: FDA Warnings
City: Miami	Language: English

The FDA issued and early communication on adverse events from Botox and Myobloc. These were mostly from off label uses of the medications, and this is an early communication.